XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Earnings & Estimates
USA - NASDAQ:XTLB - US98386D3070 - ADR
1.35 USD
+0.07 (+5.47%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||
| EBITDA YoY % growth | -1.97M | -2M -1.52% | -1.71M 14.50% | -1.25M 26.90% | N/A | |
| EBIT YoY % growth | -2.02M | -2.01M 0.50% | -1.71M 14.93% | -1.25M 26.90% | -790K 36.80% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |